ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Specialist

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,999Medicare Part D Prescriptions Filled, Including Refills

Rank: 70 out of 1262

$610K Total Retail Price of All Prescriptions

Rank: 181 out of 1262

805 Patients Receiving at Least One Drug in Part D
72% Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Florida
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

8% of this provider’s 805 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

18% of this provider’s 805 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Brand Name Drugs

15% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $101 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Florida
SIMVASTATIN 491 420 181 1 2
LISINOPRIL 482 375 173 2 6
FLUTICASONE PROPIONATE 382 294 193 3 22
HYDROCODONE-ACETAMINOPHEN 379 190 141 S3 4 5
OMEPRAZOLE 368 258 126 5 1
AMLODIPINE BESYLATE 335 295 111 6 4
ATORVASTATIN CALCIUM 293 190 121 7 12
LEVOTHYROXINE SODIUM 284 224 85 8 3
METFORMIN HCL 275 209 104 9 13
ALPRAZOLAM 273 147 74 B 10 8
METOPROLOL TARTRATE 230 170 92 11 9
MELOXICAM 200 128 86 12 34
ZOLPIDEM TARTRATE 180 122 59 13 27
WARFARIN SODIUM 178 153 41 14 31
SERTRALINE HCL 166 104 65 15 36
GABAPENTIN 160 51 63 16 7
TAMSULOSIN HCL 149 134 54 17 14
CLOPIDOGREL 141 118 50 18 11
LOSARTAN POTASSIUM 140 126 46 19 16
MONTELUKAST SODIUM 139 100 65 20 46
ATENOLOL 130 87 49 21 26
HYDROCHLOROTHIAZIDE 129 92 48 22 25
TRAMADOL HCL 118 84 53 23 20
CARVEDILOL 115 96 49 24 17
AZITHROMYCIN 106 80 84 25 67
FUROSEMIDE 103 75 45 26 10
METOPROLOL SUCCINATE 101 96* 41 27 18
GLYBURIDE-METFORMIN HCL 93 75 29 R 28 231
CLONIDINE HCL 90 74 33 29 70
GLYBURIDE 86 58 35 R 30 163
FAMOTIDINE* 79 47 32 31 123
ISOSORBIDE MONONITRATE ER 79 53 25 31 61
GLIMEPIRIDE 79 61 27 31 54
CLOTRIMAZOLE-BETAMETHASONE 78 58 59 34 134
LOSARTAN-HYDROCHLOROTHIAZIDE 78 64 27 34 86
LANTUS SOLOSTAR 77 51 31 36 84
DONEPEZIL HCL 76 76 32 37 15
ADVAIR DISKUS 74 56 35 38 44
PREDNISONE 72 50 44 39 21
OXYCODONE-ACETAMINOPHEN 71 40 28 S2 40 58
TEMAZEPAM 71 49 23 B 40 28
ALENDRONATE SODIUM 66 54 26 42 53
ENALAPRIL MALEATE 66 46 24 42 77
CRESTOR 65 45 28 44 24
GEMFIBROZIL 63 29 30 45 225
MECLIZINE HCL 61 36 31 46 169
PRAVASTATIN SODIUM 60 55* 23 47 45
GLIPIZIDE 60 55* 27 47 73
AMLODIPINE BESYLATE-BENAZEPRIL 58 37 20 49 186
LEVEMIR FLEXPEN 55 39 19 50 149
BD ULTRA-FINE PEN NEEDLE 53 35 23 51 75
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 28, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.